Since joining Kilburn & Strode in 2016, Claire has gained experience prosecuting patent applications in the UK and Europe, handling the global prosecution of patent portfolios and drafting new patent applications. Claire works with a broad range of clients across varying chemical technologies, from universities and SMEs to multinational companies. She has particular pharmaceutical expertise, including in relation to the drafting of complex patent applications relating to new chemical entities, polymorphs and pharmaceutical formulations. 
Claire also has in-house experience, obtained during a secondment to a multinational pharmaceutical company. While on secondment, Claire was involved in patent prosecution, SPC filing and prosecution and EPO appeal matters.
Claire has an MChem in Chemistry with Medicinal Chemistry from the University of Manchester and a PhD from Imperial College London. During her PhD, Claire worked on the development of new photoswitchable molecules. She also focused on the downstream applications of these molecules, such as developing photoswitchable enzyme inhibitors to allow selective targeting of disease.


MChem Chemistry with Medicinal Chemistry – University of Manchester (2012)
PhD in Chemistry – Imperial College London (2016)


Royal Society of Chemistry (RSC) - associate member
Chartered Institute of Patent Attorneys (CIPA) - student member
The Institute of Professional Representatives before the European Patent Office (EPI) - student member

K. Eldridge,J. Harris, C. Weston, Crystal clear? Patenting polymorphs in Europe, Kilburn & Strode (2020)

A. Care, L. Stallard-Stephens, C. Weston, Patents versus prizes: A Nobel case study, Kilburn & Strode, (2019)

C E Weston et al. Photoswitchable basicity through the use of azoheteroarenes, ChemComm, 52, 4521-4524 (2016)

C E Weston et al. Arylazopyrazoles: Azoheteroarene photoswitches offering quantitative isomerization and long thermal half-lives, JACS, 136, 11878-11881 (2014)

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept